Non-biological surgical sealant independent of blood coagulation of patients AQUABRID® commences clinical use in Taiwan.

Sanyo Chemical Industries, Ltd. (Head Office: Higashiyama ku, Kyoto; President and CEO: Akinori Higuchi; hereinafter “Sanyo Chemical”) announces that AQUABRID local brand name: Hydrofit ® has obtained regulatory approval* as a medical device in Taiwan and clinical use commenced in December 2021. AQUABRID is a non absorbent topical hemostatic sealant for the central circulatory system manufactured by Sanyo Chemical and marketed by Terumo Corporation, a medical device manufacturer , (Head Office: Shibuya ku, Tokyo; CEO:Shinjiro Sato).

Click here for more details

This article is a reprint of the Sanyo Chemical’s press release posted on March 1st, 2022.

SANAM is the U.S. Sales and Marketing organization of one of Japan’s leading specialty chemical producers – Sanyo Chemical Industries, Ltd. Founded in 1989, SANAM has more than 30 years of experience introducing innovative Japanese chemical products to American industry. Our multi-national team routinely handles all of the regulatory, logistical and commercial details involved with the importation of a broad range of made-to-order specialty chemical products into North America.”